Antimicrobial Agents and Chemotherapy · 1996 · 19 citations · 5 references
Life SciencesMicrobiologyVeterinary MicrobiologyBacteriologyMedical MicrobiologyMicrobial PathogenesisAntibacterial PharmacologyBacterial Gene RegulationAntibiotic Mechanisms Of ActionAntimicrobial KillingBacteriophagesBacteriostatic ActivityEscherichia ColiProphage BiologyProphage InductionTemperate Bacteriophages
Danofloxacin (CP-76,136) is in a class of agents that inhibit DNA gyrase and trigger induction of the SOS response and temperate bacteriophages. Killing studies against the bovine pathogen Pasteurella haemolytica demonstrated that danofloxacin exhibits particularly rapid killing kinetics. Here, lysogenic Escherichia coli bearing lambda is found to be more sensitive to danofloxacin than nonlysogenic E. coli. Danofloxacin exposure also induced a prophage in P. haemolytica. The potency of danofloxacin against lysogens in likely enhanced by this prophage induction.
5
A bacterial virulence determinant encoded by lysogenic coliphage λ
James J. Barondess, Jon Beckwfth · Nature · 1990 · 193 citations
Induction of the SOS response by new 4-quinolones
Ian Phillips, Esther Culebras, Felipe Moreno et al. · Journal of Antimicrobial Chemotherapy · 1987 · 190 citations
Paul R. McGuirk, Martin R. Jefson, Douglas Mann et al. · Journal of Medicinal Chemistry · 1992 · 47 citations